Dublin, Feb. 10, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/hp6nn3/performance) has announced the addition of the "Performance Nutrition Market in the UK - Market Analysis 2015-2019" report to their offering.
Performance Nutrition Market in the UK 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Protein supplements are not only consumed by individuals following a fitness regime, but are also consumed by individuals who do not have time to cook an entire meal and want to consume whole food ingredients that will provide them with balanced nutrition. Consumption of these supplements helps to build muscle, lose weight, and also benefits hair, skin, and nails. These supplements can be consumed in the form of snack bars, ready-to-drink beverages, powder, and others.
According to the report, people are opting for performance nutrition products and a fitness regime to maintain a healthy lifestyle. As a result, the gym and wellness industry in the UK is growing. Gyms and other fitness centers are customer-oriented and are built with the customers' needs in mind. Most people opting for rigorous fitness regimes choose a high protein diet to build and repair muscles. Based on the number of people opting for such fitness regimes, many gym vendors experienced a decrease in the number of customers because of the number of new entrants in the market.
Further, the report states that counterfeit products, with substandard ingredients that pose potential health risks, are a growing concern for the leading vendors.
Key vendors
- EAS Abott
- Glanbia
- GlaxoSmithKline
- Reflex Nutrition
Other prominent vendors
- Dunn's River (Grace Foods)
- For Goodness Shakes
- GNC
- Herbalife
- PHD
- Sci-Mx Nutrition
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market Landscape
PART 06: Market segmentation by product type
PART 07: Market Segmentation by Distribution Channel
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/hp6nn3/performance
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Health Food and Sports Nutrition


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



